LS Investment Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,000
| Closed | -$277K | – | 130 |
|
|
2022
Q4 | $277K | Hold |
1,000
| – | – | 0.05% | 119 |
|
|
2022
Q3 | $267K | Hold |
1,000
| – | – | 0.05% | 113 |
|
|
2022
Q2 | $204K | Buy |
+1,000
| New | +$204K | 0.04% | 126 |
|
|
2022
Q1 | – | Sell |
-1,228
| Closed | -$295K | – | 146 |
|
|
2021
Q4 | $295K | Hold |
1,228
| – | – | 0.04% | 120 |
|
|
2021
Q3 | $348K | Hold |
1,228
| – | – | 0.04% | 120 |
|
|
2021
Q2 | $425K | Sell |
1,228
-3,355
| -73% | -$1.02M | 0.05% | 114 |
|
|
2021
Q1 | $1.28M | Sell |
4,583
-750
| -14% | -$202K | 0.07% | 205 |
|
|
2020
Q4 | $1.31M | Sell |
5,333
-1,879
| -26% | -$485K | 0.07% | 246 |
|
|
2020
Q3 | $2.05M | Buy |
7,212
+48
| +0.7% | +$13.4K | 0.12% | 165 |
|
|
2020
Q2 | $1.92M | Sell |
7,164
-258
| -3% | -$77.6K | 0.12% | 161 |
|
|
2020
Q1 | $2.35M | Buy |
7,422
+485
| +7% | +$147K | 0.17% | 132 |
|
|
2019
Q4 | $2.06M | Sell |
6,937
-321
| -4% | -$89.1K | 0.11% | 179 |
|
|
2019
Q3 | $1.69M | Buy |
7,258
+62
| +0.9% | +$14.4K | 0.1% | 212 |
|
|
2019
Q2 | $1.68M | Buy |
7,196
+171
| +2% | +$39.5K | 0.1% | 206 |
|
|
2019
Q1 | $1.66M | Buy |
7,025
+191
| +3% | +$60.1K | 0.1% | 208 |
|
|
2018
Q4 | $2.06M | Buy |
6,834
+155
| +2% | +$49.5K | 0.14% | 148 |
|
|
2018
Q3 | $2.36M | Sell |
6,679
-255
| -4% | -$87.8K | 0.14% | 148 |
|
|
2018
Q2 | $2.01M | Sell |
6,934
-17
| -0.2% | -$4.78K | 0.12% | 176 |
|
|
2018
Q1 | $1.9M | Sell |
6,951
-7
| -0.1% | -$2.17K | 0.11% | 187 |
|
|
2017
Q4 | $2.22M | Buy |
6,958
+413
| +6% | +$132K | 0.13% | 155 |
|
|
2017
Q3 | $2.05M | Buy |
6,545
+258
| +4% | +$76.4K | 0.12% | 165 |
|
|
2017
Q2 | $1.71M | Sell |
6,287
-85
| -1% | -$22.5K | 0.1% | 192 |
|
|
2017
Q1 | $1.74M | Buy |
6,372
+590
| +10% | +$167K | 0.11% | 181 |
|
|
2016
Q4 | $1.64M | Buy |
5,782
+114
| +2% | +$33.8K | 0.12% | 183 |
|
|
2016
Q3 | $1.77M | Sell |
5,668
-522
| -8% | -$155K | 0.13% | 155 |
|
|
2016
Q2 | $1.5M | Buy |
6,190
+425
| +7% | +$112K | 0.1% | 200 |
|
|
2016
Q1 | $1.5M | Buy |
5,765
+614
| +12% | +$162K | 0.11% | 191 |
|
|
2015
Q4 | $1.58M | Sell |
5,151
-1,196
| -19% | -$344K | 0.12% | 162 |
|
|
2015
Q3 | $1.85M | Buy |
6,347
+454
| +8% | +$150K | 0.15% | 144 |
|
|
2015
Q2 | $2.38M | Sell |
5,893
-330
| -5% | -$132K | 0.18% | 125 |
|
|
2015
Q1 | $2.63M | Buy |
6,223
+273
| +5% | +$108K | 0.2% | 115 |
|
|
2014
Q4 | $2.02M | Buy |
5,950
+3,959
| +199% | +$1.28M | 0.16% | 134 |
|
|
2014
Q3 | $659K | Sell |
1,991
-13
| -0.6% | -$4.29K | 0.06% | 248 |
|
|
2014
Q2 | $632K | Sell |
2,004
-3,778
| -65% | -$1.14M | 0.05% | 249 |
|
|
2014
Q1 | $1.77M | Buy |
5,782
+3,639
| +170% | +$1.16M | 0.15% | 139 |
|
|
2013
Q4 | $600K | Buy |
2,143
+1,359
| +173% | +$352K | 0.05% | 215 |
|
|
2013
Q3 | $189K | Buy |
784
+128
| +20% | +$28.6K | 0.02% | 240 |
|
|
2013
Q2 | $141K | Buy |
+656
| New | +$140K | 0.02% | 241 |
|
Other funds holding BIIB
LS Investment Advisors's BIIB Position: Q1 2023 in Review
LS Investment Advisors sold out of Biogen (BIIB) in Q1 2023, closing a stake of 1,000 shares — an estimated $277K sold.
LS Investment Advisors first reported a position in BIIB in Q2 2013 and held it in 38 quarters. The position peaked at $2.63M in Q1 2015. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.
- LS Investment Advisors reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
- LS Investment Advisors sold 1,000 Biogen shares in Q1 2023, an estimated $277K.
- LS Investment Advisors first reported a position in Biogen in Q2 2013 and held it in 38 quarters.
- LS Investment Advisors's Biogen position peaked at $2.63M in Q1 2015.
- 1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.
Based on LS Investment Advisors's 13F filing for Q1 2023, filed 26 Apr 2023.